Tempus, a Chicago startup with its sights set on more a personalized and data-driven approach to cancer treatment, just announced a $70 million Series C round.
Catch up on the latest Chicago tech news with the Weekly Refresh.
Read our weekly refresh for trending Chicago tech news.
We're always looking for news.